Transplant Experts Urge Caution As CMS Weighs Expanded LVAD Coverage

Groups representing artificial heart transplant providers and researchers are advising CMS to make sure there is adequate clinical evidence before the agency expands Medicare coverage for left ventricular assist devices as a destination therapy for New York Heart Association Class IIIB patients